We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
Cap. Flow
-$5.83B
Cap. Flow %
-5.81%
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.21B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.87B
3
WMT icon
Walmart Inc
WMT
+$831M
4
AMZN icon
Amazon
AMZN
+$692M
5
LLY icon
Eli Lilly
LLY
+$641M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Consumer Discretionary 11.57%
3 Healthcare 9.79%
4 Financials 6.87%
5 Industrials 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
2701
American Well
AMWL
$181M
$232K ﹤0.01%
44,045
-43,402
-50% -$223K
OXM icon
2702
Oxford Industries
OXM
$577M
$231K ﹤0.01%
+6,000
New +$226K
ABBV icon
2703
AbbVie
ABBV
$458B
$231K ﹤0.01%
1,061
-648,939
-100% -$144M
LGCY
2704
Legacy Education Inc
LGCY
$148M
$230K ﹤0.01%
18,361
+6,372
+53% +$75.2K
MSA icon
2705
Mine Safety
MSA
$6.74B
$230K ﹤0.01%
1,400
-800
-36% -$146K
PBR.A icon
2706
CALL
Petrobras Class A
PBR.A
$107B
$229K ﹤0.01%
+12,200
New +$181K
APYX icon
2707
Apyx Medical
APYX
$165M
$228K ﹤0.01%
61,836
-46,039
-43% -$172K
FVAL icon
2708
Fidelity Value Factor ETF
FVAL
$1.28B
$228K ﹤0.01%
+3,280
New +$238K
MLCI
2709
Mount Logan Capital Inc
MLCI
$35.4M
$227K ﹤0.01%
63,440
+13,807
+28% +$87.4K
TTD icon
2710
CALL
Trade Desk
TTD
$8.13B
$227K ﹤0.01%
+10,000
New +$289K
MREO
2711
Mereo BioPharma
MREO
$45.9M
$227K ﹤0.01%
+686,987
New +$295K
ERX icon
2712
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$249M
$227K ﹤0.01%
+2,200
New +$176K
NVCT icon
2713
Nuvectis Pharma
NVCT
$609M
$226K ﹤0.01%
+29,223
New +$250K
CSX icon
2714
CALL
CSX Corp
CSX
$98.6B
$226K ﹤0.01%
5,500
FLL icon
2715
Full House Resorts
FLL
$84.5M
$225K ﹤0.01%
100,197
-111,785
-53% -$269K
ACMR icon
2716
ACM Research
ACMR
$5.83B
$225K ﹤0.01%
+5,727
New +$304K
PCG icon
2717
PUT
PG&E
PCG
$47.8B
$225K ﹤0.01%
+12,800
New +$218K
XPOF icon
2718
Xponential Fitness
XPOF
$265M
$224K ﹤0.01%
37,251
-862,695
-96% -$6.23M
PKBK icon
2719
Parke Bancorp
PKBK
$390M
$224K ﹤0.01%
+7,889
New +$215K
CFR icon
2720
Cullen/Frost Bankers
CFR
$10.3B
$223K ﹤0.01%
1,627
-1,759
-52% -$243K
ADI icon
2721
CALL
Analog Devices
ADI
$181B
$223K ﹤0.01%
+700
New +$223K
BNTX icon
2722
PUT
BioNTech
BNTX
$22.6B
$222K ﹤0.01%
2,500
-400
-14% -$41.1K
CRGY icon
2723
Crescent Energy
CRGY
$3.72B
$221K ﹤0.01%
+16,390
New +$172K
LOPE icon
2724
Grand Canyon Education
LOPE
$3.71B
$221K ﹤0.01%
+1,300
New +$218K
EQBK icon
2725
Equity Bancshares
EQBK
$1.03B
$221K ﹤0.01%
+4,976
New +$226K

Similar funds

Marshall Wace's Q1 2026 Portfolio in Review

As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.

  • Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
  • Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
  • Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
  • Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
  • Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
  • Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
  • Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.